Foamlab develops high-performance and bio-based foams from bacterial cellulose.
Foamlab has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Foamlab's investors include Capricorn Industrial Biotech Fund, SHIFT Invest, ICOS Capital Management, Value Factory Ventures, DOEN Ventures.
Foamlab is headquartered in South Holland, United States.
Foamlab develops high-performance and bio-based foams from bacterial cellulose.
Foamlab is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Foamlab — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/foamlab. Accessed September 30, 2026.
VCBacked. (2026). Foamlab — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/foamlab
{{cite web |title=Foamlab — Funding & Investors |url=https://www.vcbacked.co/company/foamlab |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated